Based on the provided context, there is no information about CYP2C19 and allergies. In general, CYP2C19 is a drug-metabolizing enzyme (CYP450) primarily relevant for processing medications like clopidogrel and proton pump inhibitors. Some research explores associations with drug allergies or immune modulation, but evidence for a direct role in common allergies (e.g., pollen, food) is weak and not established. Consumer DNA tests claiming CYP2C19 variants predict allergy risk often overstate the science. Current clinical utility is limited to pharmacogenetics. Anyone considering such a test should understand that allergies are multifactorial; genetic variants like CYP2C19 contribute little, if at all. Medical evaluation with specific IgE testing or provocation remains the gold standard.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-d7fb5257ecc3802ea705069b